What Data Says About Biologics-Related Ex Parte Challenges

By Fievel Lim, Michael Green and John Molenda ( July 10, 2026, 6:08 PM EDT) -- Recent patent-owner-friendly rule changes to the Patent Trial and Appeal Board's inter partes review and postgrant review procedures may hinder future challenges, inducing petitioners to consider an alternative procedure, ex parte reexamination....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Patents